Summary of Key Points Core Viewpoint The company, O-Film Group Co., Ltd., is changing the use of part of its raised funds and adding new investment projects to enhance its optical lens production capabilities, aligning with market demands and strategic planning. Group 1: Fundraising and Investment Changes - The total amount raised from the non-public offering was approximately 3.53 billion RMB, with a net amount of about 3.51 billion RMB after deducting issuance costs [1][2] - The company plans to adjust the investment amounts for existing projects, reducing the funding for the "High Pixel Optical Lens Construction Project" by 200 million RMB and reallocating it to a new project focused on optical lenses and lenses for smart vehicles, VR/AR, and other applications [2][5] - The new investment project aims to upgrade and expand the production line for high-precision optical lenses, introducing advanced production equipment to enhance production capacity [5][10] Group 2: Market Context and Strategic Alignment - The global optical lens market is projected to grow from 45.29 billion RMB in 2019 to 68.28 billion RMB in 2023, with a CAGR of 10.81% [11][12] - The Chinese optical lens market reached 16.13 billion RMB in 2023, with a forecasted growth to 17.39 billion RMB in 2024 [12] - The company is focusing on high-end products to meet the increasing demand for high-performance lenses in smartphones and smart vehicles, as well as in consumer electronics and other emerging fields [9][10] Group 3: Project Feasibility and Economic Benefits - The new project is expected to generate an annual revenue of approximately 804 million RMB and a net profit of about 69.49 million RMB once it reaches full production [18] - The project has a payback period of 8.12 years and an internal rate of return of 12.20%, indicating good economic viability [18] - The company has a strong production capacity and technical foundation in the optical lens sector, which supports the feasibility of the new project [18][19] Group 4: Regulatory Compliance and Approval Process - The changes to the fundraising and investment projects have been approved by the company's board and supervisory committee, and are awaiting shareholder approval [24][25] - The adjustments are in compliance with relevant regulations and are aimed at optimizing resource allocation and improving the efficiency of fund usage [24][25][26]

关于欧菲光集团股份有限公司 限制性股票第一个解除限售期解除限售条件成就及 回购注销部分限制性股票事项 的法律意见书 中国 深圳 福田区 益田路 6001 号太平金融大厦 11、12 楼 邮政编码：518038 电话(Tel.)：(0755) 8826 5288 传真(Fax.)：(0755) 8826 5537 网址（Website）：www.sundiallawfirm.com 法律意见书 广东信达律师事务所 关于欧菲光集团股份有限公司 第一个解除限售期解除限售条件成就及回购注销部分限制性股票事 项的法律意见书 信达励字（2025）第083号 致：欧菲光集团股份有限公司 广东信达律师事务所（以下简称"信达"）接受欧菲光集团股份有限公司（以 下简称"欧菲光"或"公司"）的委托，担任公司本次实行 2024 年第一期限制 性股票与股票期权激励计划（以下简称"本股权激励计划""本计划""本激励 计划"）的专项法律顾问。信达根据《中华人民共和国公司法》（以下简称"《公 司法》"）、《中华人民共和国证券法》（以下简称"《证券法》"）、《上市 公司股权激励管理办法》（以下简称"《管理办法》"）等有关法律、法规和规 范性文 ...

Group 1 - The Shanghai Composite Index has recently surpassed the annual high set on March 18, 2025, and is approaching the high from October 8, 2024, indicating a significant market movement [1] - There is a noticeable divergence among various sectors, with banking, agriculture, personal care, military, chemical, transportation, and petrochemical industries showing a higher proportion of stocks exceeding their March 18, 2025 closing prices [1] - Conversely, sectors such as steel, electronics, home appliances, telecommunications, computers, and electrical equipment have a lower proportion of stocks exceeding their March 18, 2025 levels [1] Group 2 - In the secondary industry analysis, financial (banking, insurance, diversified finance), military (naval equipment, ground weaponry), agriculture (animal health, agricultural products, planting, feed), precious metals, personal care products, and chemical pharmaceuticals show a higher proportion of stocks exceeding their March 18, 2025 closing prices [4] - Sectors like home appliances, electrical equipment, TMT (television broadcasting, communication services, consumer electronics, semiconductors, optical electronics), general steel, and machinery (engineering machinery, automation equipment) have a lower proportion of stocks exceeding their March 18, 2025 levels [4] - Comparing to the October 8, 2024 closing prices, banking, motorcycles, military (ground weaponry, aerospace equipment), chemicals (plastics, non-metallic materials), and new consumption (entertainment products, personal care products, retail, accessories) show a higher proportion of stocks exceeding their previous levels [4]

Group 1: Company Overview and Business Development - Dongtian Micro currently does not produce Faraday rotation plates but procures them for optical isolator production [1] - In 2024, the company's optical communication business achieved revenue of 1.24 billion yuan, a year-on-year growth of 101.65% [1] - The company aims to strengthen its existing business while seizing opportunities in the data communication market, focusing on the delivery of optical isolators and the development of new products like z-blocks and optical components [1] Group 2: Market Trends and Product Outlook - The global smartphone shipment in 2024 is projected to reach 1.24 billion units, a year-on-year increase of 6.4%, with China's market expected to see shipments of approximately 400 million units, growing by 2.86% [2] - The demand for high-speed optical modules, particularly 800G and 1.6T products, is expected to rise due to increasing AI computing power, driving the need for optical components [2] - The market for smartphone micro-prisms is significant, with high unit value and low current penetration, indicating substantial growth potential [2] Group 3: Technological Advancements - The spin-coating filter technology offers high absorption rates in the near-infrared spectrum, significantly improving image quality for high-end smartphone cameras [2]

Group 1 - The company, O-Film, announced on June 27 that it will hold the eighth (temporary) meeting of the sixth board of directors on June 27, 2025, to review the proposal for changing part of the fundraising purpose and adding new investment projects [2] - The company agreed to change the use of part of the raised funds, reallocating 200 million yuan from the "Hefei Jingchao Optical Technology Co., Ltd. Optical Lens and Lens Production Line Project" and 353.7568 million yuan from the "High-Pixel Optical Lens Construction Project" to the new project "High-Precision Optical Lens Production Line Upgrade and Expansion Project" [2] - The total amount of funds involved in this change is 553.7568 million yuan, which accounts for 15.76% of the net amount raised from the company's non-public stock issuance [2] Group 2 - The company’s revenue composition for the year 2024 is entirely from the manufacturing of optical and optoelectronic components, accounting for 100.0% [3]

| | ☑特定对象调研 □媒体采访 | □分析师会议 □业绩说明会 | | --- | --- | --- | | 投资者关系活动 | | | | 类别 | □新闻发布会 | □路演活动 | | | □现场参观 | | | | □其他 （请文字说明其他活动内容） | | | | 华西证券 陈天然 | 泾溪投资 方彦 | | | 朋元资产 秦健丽 | 鹏扬基金 章宏帆 | | | 申万菱信 徐巡 | 东证证券 曹伏飙 | | | 天风证券 骆奕扬 | 翊安投资 张益锋 | | | 阳光资产 张凌禹 | 趣时资产 冯郡 | | | Pinpoint 倪韬 | 北京骏远资产 王存迎 | | | 知盈投资 张严冬 | 中金公司 胡炯益 | | 活动参与人员 | 财通证券 黄梦龙 | 上海证券 梁瑞 | | | 上海证券报 柴刘斌 | 银泰证券资管 杨皓 | | | 东兴证券 李科融 | 路演时代 曹力丹 | | | 浩期私募基金 肖滨 | 长江证券 盛硕文 | | | 新狮峰投资 孙飞 | 上海贤盛投资管理 郑力豪 | | | 中国船舶集团投资公司 | 任丽 | | | 长江证券资产管理 张剑鑫 | | | | 内蒙 ...

1 地的定位进行调整，台州生产基地将是北美大客户的核心实践基地，江西鹰潭基地 将是国内大循环的核心实践基地，越南生产基地将是海外循环的核心实践基地。 当前公司已经构建以智能手机为代表的第一成长曲线、以汽车电子为代表的第 二成长曲线以及以 AR 眼镜为代表的第三成长曲线。 智能手机业务是公司主要收入来源之一。其中，IRCF 红外截止滤光片主要用于 手机摄像头，多年来公司保持全球领先的市场份额。其升级产品涂布滤光片产品， 过去多年在安卓客户端公司保持较高的市场份额，在今年公司也在涂胶端成功切入 北美大客户供应链，未来随着公司份额逐步提升有望带来较好的业绩成长空间。 2020 年公司通过薄膜光学面板业务开始直接与北美大客户合作，过去几年随着公司 份额爬坡，薄膜光学面板业务快速成长为公司的第二大支柱业务，并且达到了较高 的市场份额，未来其增长空间主要来自于非手机业务的新增订单。2023 年公司微棱 镜产品在大客户最高端机型上首次量产落地，是业界首创。微棱镜产品的顺利落地 使客户对公司的技术工艺开发能力和自动化开发能力有了进一步认可。现在公司已 经和客户进入了战略合作伙伴的新阶段，为客户实现光学创新升级落地和开发，公 ...

Group 1: Company Announcements - Jingce Electronics' subsidiary signed sales contracts for semiconductor measurement equipment totaling 113 million yuan [1] - Zhifei Biological plans to issue company bonds not exceeding 6 billion yuan for technology innovation and working capital [1] - Rijiu Optoelectronics' subsidiary plans to invest 822 million yuan in a functional film project with an annual production capacity of 6 million square meters [1] - Huiyun Titanium Industry's subsidiary intends to acquire a 53.125% stake in Chenshang Mining for 30.6 million yuan and increase capital by 32.4 million yuan [2] - Hongte Technology plans to raise up to 650 million yuan through a rights issue for various projects and working capital [2] - Jincheng Pharmaceutical's subsidiary received FDA approval for the active pharmaceutical ingredient Posaconazole [4] - Kairun Co. plans to reduce its shareholding by up to 2% due to personal funding needs [5] - Rundou Co. passed an FDA inspection for nine active pharmaceutical ingredients [6] - Sanyou Lianzhong's shareholders plan to reduce their holdings by up to 3% due to funding needs [7] - *ST Yazhen's stock was suspended for trading due to a significant price increase of 29.43% [9] - Online and Offline plans to change control with a share transfer agreement, leading to a new controlling shareholder [10] - Dazhong Mining intends to purchase office space from an affiliate for 50.17 million yuan [11] - Suzhou Bank's major shareholder increased its stake by 856 million yuan [12] - *ST Fanli's subsidiary plans to acquire a 60% stake in Guangzhou Fengteng for up to 28.8 million yuan [14] - Hengmingda's major shareholders plan to reduce their holdings by up to 3.15% [16] - Guomai Technology's shareholder plans to reduce its stake by up to 1% due to funding needs [17] - ST Bailin's stock will change its name to Guizhou Bailin and remove risk warnings [17] - *ST Xianfeng's stock will change its name to Xianfeng Holdings and remove risk warnings [18] - Maiwei Bio signed an exclusive licensing agreement with CALICO for a monoclonal antibody, receiving an upfront payment of 25 million USD [19] - Maiwei Bio signed a technology licensing agreement with Qilu Pharmaceutical for a new drug project, with a total payment of up to 500 million yuan [21] - Maiwei Bio plans to repurchase shares worth between 25 million and 50 million yuan [22] - Mengwang Technology plans to acquire 100% of Bicheng Digital for 1.28 billion yuan to expand its e-commerce services [22] Group 2: Industry Overview - Jingce Electronics operates in the mechanical equipment sector, focusing on measurement systems for displays, semiconductors, and new energy [1] - Zhifei Biological is in the pharmaceutical sector, specializing in vaccine and biological product development [1] - Rijiu Optoelectronics is part of the electronics industry, focusing on touch display materials and functional films [1][2] - Huiyun Titanium Industry operates in the basic chemicals sector, focusing on titanium dioxide products [2] - Hongte Technology is in the automotive industry, specializing in aluminum alloy precision die-casting for automotive components [2][3] - Jincheng Pharmaceutical is in the pharmaceutical sector, focusing on chemical pharmaceuticals and active ingredients [4] - Rundou Co. operates in the pharmaceutical sector, focusing on chemical drug formulations and raw materials [6] - Sanyou Lianzhong is in the electrical equipment sector, specializing in relays and transformers [7] - *ST Yazhen operates in the light industry, focusing on high-end furniture products [9] - Online and Offline is in the communication sector, focusing on communication services and applications [10] - Dazhong Mining operates in the steel industry, focusing on iron ore mining and processing [11] - Suzhou Bank is a city commercial bank, providing various banking services [12] - *ST Fanli operates in the media sector, focusing on online advertising and marketing services [14] - Hengmingda is in the electronics sector, focusing on precision components for consumer electronics [16] - Guomai Technology operates in the education sector, focusing on IoT technology services [17] - ST Bailin is in the energy sector, providing engineering consulting and smart factory solutions [17] - *ST Xianfeng operates in the animal health sector, focusing on vaccines and animal nutrition [18] - Maiwei Bio is in the pharmaceutical sector, focusing on biopharmaceuticals [19][21][22] - Mengwang Technology operates in the communication sector, focusing on cloud platform services [22]

Market Overview - The A-share market showed slight fluctuations on June 27, with the Shanghai Composite Index up by 0.05%, the Shenzhen Component Index up by 0.29%, and the ChiNext Index up by 0.37% [1] - Dongfang Securities noted that maintaining stability in the capital market has become a clear policy goal, with the domestic economic fundamentals remaining stable and improving, leading to a recovery in market risk appetite [1][7] Sector Performance - The Xiaomi automotive sector experienced significant gains, with Kaizhong Co. hitting the daily limit, and Haitai Technology and Fute Technology also rising [1][3] - AI glasses concept stocks were active, with Zhongguangxue hitting the daily limit for three consecutive days, and other stocks like OFILM and Sitake also seeing increases [1] Institutional Insights - Shenwan Hongyuan indicated that a short-term consolidation is needed, but a significant drop is not expected. The focus is on potential capital expenditure increases from internet giants in July and August [6] - Dongfang Securities highlighted that July's performance will be a key factor for stock price movements, with bank stocks showing strength and several reaching historical highs [7] - According to Everbright Securities, the market may return to index fluctuations and sector rotation after a period of continuous gains, with a lack of new catalysts [8]

《深圳证券交易所股票上市规则》、 《深圳证券交易所上市公司自律监 管指引第 1 号——主板上市公司规范运作》和《亚世光电（集团）股份有限公司 章程》 亚世光电（集团）股份有限公司 第一章 总则 第一条 为了规范亚世光电（集团）股份有限公司(以下简称"公司")与控 股股东、实际控制人及其他关联方的资金往来，最大程度保护投资者合法权益， 避免控股股东、实际控制人及其他关联方资金占用行为的发生，根据《中华人民 《上市公司监管指引第 8 号——上市公司资金往来、对外担保的 共和国公司法》、 监管要求》、 （以下简称"《公司章程》"）以及其他法律、法规及规范性文件的有关规定， 制定本制度。 第二条 公司及纳入公司合并会计报表范围的子公司与控股股东、实际控制 人及其他关联方之间资金往来适用本制度。 除本条规定外，本制度所称的公司均指公司及纳入公司合并会计报表范围的 子公司。 第三条 本制度所称资金占用包括但不限于：经营性资金占用和非经营性资 金占用。经营性资金占用是指控股股东、实际控制人及其他关联方通过采购、销 售等生产经营环节的关联交易产生的资金占用；非经营性资金占用是指公司为控 股股东、实际控制人及其他关联方垫支工资 ...